Erlotinib/osimertinibAcquired drug resistance: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1753卷 / 1期

关键词：

D O I：

10.1007/s40278-019-62053-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：161 / 161

相关论文

共 50 条

[1] Erlotinib/gefitinib/osimertinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2021, 1856 (1) : 201 - 201
[2] Erlotinib/gefitinib/osimertinibAcquired drug resistance: 3 case reports
Reactions Weekly, 2019, 1752 (1) : 158 - 158
[3] Erlotinib/osimertinibAcquired drug resistance: case report
Reactions Weekly, 2020, 1826 (1) : 127 - 127
[4] Erlotinib/osimertinibAcquired clinical drug resistance: case report
Reactions Weekly, 2022, 1899 (1) : 185 - 185
[5] OsimertinibAcquired drug resistance: 22 case reports
Reactions Weekly, 2020, 1829 (1) : 304 - 304
[6] OsimertinibAcquired drug resistance: 3 case reports
Reactions Weekly, 2023, 1944 (1) : 460 - 460
[7] OsimertinibAcquired drug resistance: 4 case reports
Reactions Weekly, 2022, 1911 (1) : 340 - 340
[8] OsimertinibAcquired drug resistance: 3 case reports
Reactions Weekly, 2021, 1877 (1) : 318 - 318
[9] Erlotinib/osimertinibAcquired resistance: case report
Reactions Weekly, 2021, 1880 (1) : 179 - 179
[10] Erlotinib/osimertinibAcquired resistance: case report
Reactions Weekly, 2022, 1916 (1) : 198 - 198

← 1 2 3 4 5 →